Skip Navigation
Department of Health and Human Services www.hhs.gov
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Presentation to Slide Tray Presentation:

Disease-Modifying Antirheumatic Drugs in Children With Juvenile Idiopathic Arthritis

Slide: 25 of 46

Summary of Results: Adding Biologic DMARDs to JIA Treatment (Methotrexate Permitted)

Disease activity improved when biologic DMARDs were added to treatment, but the statistical significance of these effects is not established. Health status improved when biologic DMARDs were added to treatment.

Improvements in a measure of inflammation, ESR, were inconsistent across studies. Radiographic evidence of progression was not reported.